Objective
Medical technology development is a research growth area for SingHealth with the aim of bringing novel healthcare technology solutions to the patients' bedside. Its advancement is a mission spearheaded by the SingHealth Medical Technology Office (MTO). One of MTO's key roles is to link researchers and their validated clinical problem with technological solutions – with an end goal of improving patient care through clinically relevant technology.
The SingHealth Duke-NUS Academic Medicine (AM) & National Health Innovation Centre Singapore (NHIC) Joint MedTech Grant Call is jointly supported by SingHealth Duke-NUS AM and NHIC - to fund feasibility studies and deserving pilot projects prior to embarking on the NHIC applications.
This grant aims to provide seed funding for investigators to explore novel research ideas, support exploratory efforts for early-stage projects that involve an unmet clinical need and show potential for further development with the next stage of Proof of Concept (POC) funding.
Funding Details
The grant award is up to S$100,000 over a period of 1 year.
The end deliverable should be a physical clinical device, drug or diagnostic solution, potentially applicable in SingHealth Duke-NUS Academic Medicine Centre (AMC) and optimally, across other healthcare institutions; and/or show potential for patent protection.
Projects should aim towards securing follow-on funding [such as NHIC Innovation to Develop (I2D) Grant, SMART Innovation 2.0 Grant and NRF Central Gap fund] or take other concrete steps to develop the technology towards commercialization, at the end of the project.
Eligibility Criteria
Only investigators/researchers primarily employed in SingHealth and her member institutions are encouraged to apply provided the following criteria are fulfilled:
Principal Investigators (PIs) with previous MedTech research funding (irrespective of funding source) of <S$1 million in total between the period 1 September 2022 to 31 August 2024 are eligible to apply.
PIs (other than Allied Health professionals and Nurses) must not have held more than 1 SHF-Foundation/AM grant (i.e. a maximum of 2 SHF-Foundation/AM grants may be awarded to any PI who is not an Allied Health professional or Nurse); Allied Health professionals and Nurses must not have held more than 2 SHF-Foundation/AM grants (i.e. a maximum of 3 SHF-Foundation/AM grants may be awarded if the PI is an Allied Health professional or Nurse).
Association/Affiliation with an Academic Clinical Programme (ACP):
The PI must be under an ACP or contributing to the growth and development of research in/under an ACP through active collaboration. Justifications must be given to support these research contributions and activities.
Applicants will need to complete a self-declaration on the ACP to which their research has contributed and obtain acknowledgement from the respective ACP Vice Chair (Research).'
If the applicant is unable to fulfil the above condition (i), the applicant should have his/her proposal signed-off by the relevant ACP Vice Chair (Research) and have it endorsed by the ACP's Academic Chair while keeping the respective ACP Administrators informed. The signing-off in support and as endorsement of the proposal signifies that the applicant is associated to the ACP.
The proposed research project must be conducted within the SingHealth Duke-NUS academic health system and the PI must have an official employment (permanent/contract) in a SingHealth institution throughout the effective grant period.
PIs must not be recipients of NMRC’s Transition Award (TA) or Clinician Scientist Award (CSA); or be current recipients of SingHealth Duke-NUS AM’s Nurturing Clinician Scientist Scheme (NCSS) or Khoo Mentored Research Award (KMRA); or have been hired under SingHealth Research Strategic Hire or Research Talent schemes, at the point of application and upon award.
The project's aims and objectives, and/or the same protocol have not been funded by other funding agencies.
If eligible, successful (awarded) investigators must apply for follow-on funding [such as NHIC Innovation to Develop (I2D) Grant, SMART Innovation Grant 2.0 and NRF Central Gap fund] or take other concrete steps to develop the technology towards commercialization (details of which must be provided to the grant implementing agencies), at the end of the project.
All awarded investigators will need to agree to have a project monitor for their project, assigned by MTO and mutually agreed on by the PI.
Applications that do not fulfil the eligibility criteria will be automatically disqualified from review.
Submission
Each eligible applicant can only submit one application per SingHealth Duke-NUS AM Research Grant Call as the PI (i.e. a PI can only apply for either ‘SingHealth Duke-NUS AM & NHIC Joint MedTech Grant Call FY2025’ or ‘SingHealth Duke-NUS AM Research Grant 2.0 FY2025’).
(1 in word format without signatures and 1 in PDF format with signatures) Electronic signatures are allowed.
Important Notes:
Contact Person
SingHealth Office of Research (OoR)
Ms Tan Yi Mei; Email: tan.yi.mei@singhealth.com.sg
Ms Ang Shu Wei; Email: ang.shu.wei@singhealth.com.sg
Dr See Jie Yang: Email: see.jie.yang@singhealth.com.sg
Additional Information
SingHealth Duke-NUS AM and NHIC Joint MedTech Grant Call FY2025 - Application Form.docx
SingHealth Institutional Research Admin Contact List (Aug 2024).pdf
Annex 1 - SingHealth Duke-NUS AM Research Grant Funding Guidelines.pdf
ACP Academic Vice Chair, Research and Administrators Contact list (Aug 2024).pdf
SingHealth Duke-NUS AM and NHIC Joint MedTech Grant Call FY2025 - Guidelines.pdf
© 2025 SingHealth Group. All Rights Reserved.